Prochlorperazine Maleate
NDC Package 10544-511-06
Package Information
Prochlorperazine Maleate is a medication used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Marketed by Blenheim Pharmacal, Inc., this product is identified by NDC 10544-511 and is authorized under FDA application ANDA040268.
Identification & Billing
- RxCUI: 198365 - prochlorperazine maleate 10 MG Oral Tablet
- RxCUI: 198365 - prochlorperazine 10 MG Oral Tablet
- RxCUI: 198365 - prochlorperazine (as prochlorperazine maleate) 10 MG Oral Tablet
- RxCUI: 312635 - prochlorperazine maleate 5 MG Oral Tablet
- RxCUI: 312635 - prochlorperazine 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10544 - Blenheim Pharmacal, Inc.
- 10544-511 - Prochlorperazine Maleate
- 10544-511-06 - 6 TABLET in 1 BOTTLE
- 10544-511 - Prochlorperazine Maleate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10544-511-06 identifies a specific commercial package of 6 tablet in 1 bottle of Prochlorperazine Maleate, labeled by Blenheim Pharmacal, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 6 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Blenheim Pharmacal, Inc. on April 01, 2011. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery.
How is this Blenheim Pharmacal, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10544051106. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 6 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.